Participants 132 159 3
acute myocardial infarction
Participants 305 348 3
therapy of acute myocardial infarction (MI)
Participants 413 519 8
122 patients with evolving MI to PTCA therapy with or without adjunctive intravenous streptokinase therapy
Participants 541 709 5
Patients with ECG ST segment elevation who presented within 4 hours of symptom onset, had no contraindication to thrombolytic therapy, and were not in cardiogenic shock
Participants 755 820 3
with intravenous heparin (10,000 units) and oral aspirin (325 mg)
Participants 839 892 3
treatment with placebo or streptokinase (1.5 M units)
Participants 1199 1234 5
106 patients were treated with PTCA
